Workflow
桂林三金(002275) - 2015年1月23日投资者关系活动记录表
002275Guilin Sanjin(002275)2022-12-07 09:20

Group 1: Company Overview and Strategic Goals - Guilin Sanjin aims to modernize traditional Chinese medicine through innovation, focusing on modern Chinese medicine preparations as its core industry [2] - The company plans to expand its vertical industry chain and explore fields such as biopharmaceuticals, chemical drugs, and health products to enhance its professional management level [3] Group 2: Health Industry Development - After integrating Guilin Sanjin Watermelon Frost Ecological Company into its listing system, the company will focus on research and development in the health sector, leveraging its market and brand advantages in throat-related traditional Chinese medicine [3] - The company intends to develop oral care products like Watermelon Frost toothpaste to extend its product line and optimize its business structure [3] Group 3: Biopharmaceuticals and Future Plans - Baoshuan Biotech, established in 2005, specializes in the research and production of biopharmaceuticals, with several biosimilar drugs under development targeting malignant tumors [4] - The company aims to submit 1-2 products for clinical trials within the year [4] Group 4: Expansion and Acquisition Strategy - To maintain its leading position in the traditional Chinese medicine industry, Guilin Sanjin is actively seeking strategic acquisitions of quality domestic pharmaceutical companies [4] - The company plans to capitalize on the upcoming deadline for new GMP certification to acquire pharmaceutical enterprises with strong product and resource advantages [4]